One speculative explanation is that the increased risk of severe disease attributable to chronic lung disease in smokers is counterbalanced by a protective effect—the blunted cytokine response of smokers AMs responding to SARS‐CoV‐2 envelope protein that we observed. This evidence concerns the gene ERVW-1 and chronic lung disease.